NIH Releases Mpox Research Agenda - National Institute of Allergy …
WEB3 days ago · As part of the U.S. government response to the current mpox outbreak, the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has released an update on its priorities for mpox research DOC.
Newsroom - National Institute of Allergy and Infectious Diseases …
WEBAug 22, 2024 · Newsroom | NIAID: National Institute of Allergy and Infectious Diseases. News & Events. Newsroom. Latest News Releases. NIH Awards Will Support Innovation in Syphilis Diagnostics. September 03, 2024. The Antiviral Tecovirimat is Safe but Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo. August 15, 2024.
NIH awards establish pandemic preparedness research network
WEBSep 13, 2024 · NIAID. The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by …
NIH launches clinical trials network to test COVID-19 vaccines …
WEBJul 8, 2020 · The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.
NIH clinical trial shows Remdesivir accelerates recovery from …
WEBApr 29, 2020 · Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21.
New director named at National Institute of Allergy and Infectious ...
WEBAug 2, 2023 · Dr. Jeanne Marrazzo will be the next director of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health announced Wednesday. Marrazzo is expected to...
It Ain’t Over Till It’s Over…but It’s Never Over — Emerging and ...
WEBNov 26, 2022 · The global impact of this disease is staggering: since the start of the pandemic, more than 84 million people have been infected with HIV, the virus that causes AIDS, of whom 40 million have...
Fauci on the efficacy of new vaccines and preparing for ... - PBS
WEBJan 29, 2021 · Anthony Fauci, the director of the National Institute of Allergy and Infectious Diseases at the NIH and a top adviser to President Biden on the pandemic, joins Judy Woodruff to...
Anthony Fauci to step down in December as Biden's lead ... - NBC News
WEBAug 22, 2022 · Dr. Anthony Fauci will leave as director of the National Institute of Allergy and Infectious Diseases and as chief medical adviser to President Joe Biden in December, Fauci announced Monday.
National Institute of Allergy and Infectious Diseases (NIAID)
WEBAs part of the U.S. government response to the current mpox outbreak, the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has released an update on its priorities for mpox research.